Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 92.50M | $ 82.80M | $ 34.60M | $ 150.50M | $ 137.80M |
Total Assets | $ 815.80M | $ 819.10M | $ 819.80M | $ 1.23B | $ 1.30B |
Total Debt | $ 373.00M | $ 371.50M | $ 375.60M | $ 715.30M | $ 715.10M |
Net Debt | $ 280.50M | $ 288.70M | $ 341.00M | $ 564.80M | $ 577.30M |
Total Liabilities | $ 406.30M | $ 405.00M | $ 417.70M | $ 765.50M | $ 777.80M |
Stockholders Equity | $ 409.50M | $ 414.10M | $ 402.10M | $ 460.40M | $ 518.20M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |